Structural and functional effects of cytochrome b5 interactions with human cytochrome P450 enzymes

被引:45
|
作者
Bart, Aaron G. [1 ]
Scott, Emily E. [1 ,2 ,3 ]
机构
[1] Univ Michigan, Biophys Program, Ann Arbor, MI 48109 USA
[2] Univ Michigan, Dept Med Chem, 428 Church St, Ann Arbor, MI 48109 USA
[3] Univ Michigan, Dept Pharmacol, Ann Arbor, MI 48109 USA
基金
美国国家卫生研究院;
关键词
ESCHERICHIA-COLI; BACULOVIRUS EXPRESSION; MICROSOMAL CYTOCHROME; 17,20-LYASE ACTIVITY; MASS-SPECTROMETRY; BINDING-SITE; HUMAN LIVER; 2E1; PURIFICATION; REDUCTASE;
D O I
10.1074/jbc.RA117.000220
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The small heme-containing protein cytochrome b(5) can facilitate, inhibit, or have no effect on cytochrome P450 catalysis, often in a P450-dependent and substrate-dependent manner that is not well understood. Herein, solution NMR was used to identify b(5) residues interacting with different human drug-metabolizing P450 enzymes. NMR results revealed that P450 enzymes bound to either b(5) alpha 4-5 (CYP2A6 and CYP2E1) or this region and alpha 2-3 (CYP2D6 and CYP3A4) and suggested variation in the affinity for b(5). Mutations of key b(5) residues suggest not only that different b(5) surfaces are responsible for binding different P450 enzymes, but that these different complexes are relevant to the observed effects on P450 catalysis.
引用
收藏
页码:20818 / 20833
页数:16
相关论文
共 50 条
  • [31] Expression, Function and Regulation of Mouse Cytochrome P450 Enzymes: Comparison With Human Cytochrome P450 Enzymes
    Hrycay, E. G.
    Bandiera, S. M.
    CURRENT DRUG METABOLISM, 2009, 10 (10) : 1151 - 1183
  • [32] Catalytic enhancements in cytochrome P450 2C19 by cytochrome b5
    Lee, Gyu-Hyeong
    Kim, Vitchan
    Lee, Sung-Gyu
    Jeong, Eunseo
    Kim, Changmin
    Lee, Yoo-Bin
    Kim, Donghak
    TOXICOLOGICAL RESEARCH, 2024, 40 (02) : 215 - 222
  • [33] Catalytic enhancements in cytochrome P450 2C19 by cytochrome b5
    Gyu-Hyeong Lee
    Vitchan Kim
    Sung-Gyu Lee
    Eunseo Jeong
    Changmin Kim
    Yoo-Bin Lee
    Donghak Kim
    Toxicological Research, 2024, 40 : 215 - 222
  • [34] The effect of cytochrome b5 on a reaction cycle of cytochrome P450 1A1
    Indra, R.
    Milichovsky, J.
    Moserova, M.
    Arlt, V. M.
    Stiborova, M.
    TOXICOLOGY LETTERS, 2015, 238 (02) : S286 - S286
  • [35] Effects of Membrane Mimetics on Cytochrome P450-Cytochrome b5 Interactions Characterized by NMR Spectroscopy
    Zhang, Meng
    Huang, Rui
    Im, Sang-Choul
    Waskell, Lucy
    Ramamoorthy, Ayyalusamy
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2015, 290 (20) : 12705 - 12718
  • [36] Stimulation of cytochrome P450 reactions by apo-cytochrome b5 -: Evidence against transfer of heme from cytochrome P450 3A4 to apo-cytochrome b5, or heme oxygenase
    Yamazaki, H
    Shimada, T
    Martin, MV
    Guengerich, FP
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2001, 276 (33) : 30885 - 30891
  • [37] Protonation of the Hydroperoxo Intermediate of Cytochrome P450 2B4 Is Slower in the Presence of Cytochrome P450 Reductase Than in the Presence of Cytochrome b5
    Pearl, Naw May
    Wilcoxen, Jarett
    Im, Sangchoul
    Kunz, Ryan
    Darty, Joseph
    Britt, R. David
    Ragsdale, Stephen W.
    Waskell, Lucy
    BIOCHEMISTRY, 2016, 55 (47) : 6558 - 6567
  • [38] Approach to predict the contribution of cytochrome P450 enzymes to drug metabolism in the early drug-discovery stage:: The effect of the expression of cytochrome b5 with recombinant P450 enzymes
    Emoto, C.
    Iwasaki, K.
    XENOBIOTICA, 2007, 37 (09) : 986 - 999
  • [39] Cytochrome p450 enzymes
    Donaldson, D
    JOURNAL OF THE ROYAL SOCIETY FOR THE PROMOTION OF HEALTH, 2000, 120 (03): : 150 - 151
  • [40] Differential effects on human cytochromes P450 by CRISPR/Cas9-induced genetic knockout of cytochrome P450 reductase and cytochrome b5 in HepaRG cells
    Heintze, Tamara
    Klein, Kathrin
    Hofmann, Ute
    Zanger, Ulrich M.
    SCIENTIFIC REPORTS, 2021, 11 (01)